These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19864122)

  • 61. Perinatal characteristics and schizophrenia: electrodermal activity as a mediating link in a vulnerability-stress perspective.
    Hultman CM; Ohman A
    Int J Dev Neurosci; 1998; 16(3-4):307-16. PubMed ID: 9785127
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The niacin response biomarker as a schizophrenia endophenotype: A status update.
    Messamore E
    Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():95-97. PubMed ID: 28688777
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Test for abnormal niacin response syndrome in schizophrenia: reclaiming the oral route].
    Carena F; Martino P; Vera CF; Bonet J
    Vertex; 2023 Oct; 34(161, jul.-sept.):24-31. PubMed ID: 37819066
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Electrodermal activity in euthymic patients with affective disorders: one-year retest stability and the effects of stimulus intensity and significance.
    Iacono WG; Lykken DT; Haroian KP; Peloquin LJ; Valentine RH; Tuason VB
    J Abnorm Psychol; 1984 Aug; 93(3):304-11. PubMed ID: 6470315
    [No Abstract]   [Full Text] [Related]  

  • 65. SKINREMS-A New Method for Assessment of the Niacin Skin Flush Test Response in Schizophrenia.
    Karakula-Juchnowicz H; Rog J; Wolszczak P; Jonak K; Stelmach E; Krukow P
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545806
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A potential objective marker in first-episode schizophrenia based on abnormal niacin response.
    Hu Y; Xu L; Gan R; Wu G; Tang X; Wei Y; Cui H; Hui L; Tang Y; Li C; Chen T; Wan C; Wang J; Zhang T
    Schizophr Res; 2022 May; 243():405-412. PubMed ID: 34187733
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Electrodermal recovery rate in a schizophrenic population.
    Maricq HR; Edelberg R
    Psychophysiology; 1975 Nov; 12(6):630-3. PubMed ID: 1187965
    [No Abstract]   [Full Text] [Related]  

  • 68. Electrodermal responsiveness as related to psychiatric diagnosis and prognosis.
    Stern JA; Surphlis W; Koff E
    Psychophysiology; 1965 Jul; 2(1):51-61. PubMed ID: 5830495
    [No Abstract]   [Full Text] [Related]  

  • 69. Electrodermal nonresponding among college undergraduates: temporal stability, situational specificity, and relationship to heart rate change.
    Simons RF; Losito BD; Rose SC; MacMillan FW
    Psychophysiology; 1983 Sep; 20(5):498-506. PubMed ID: 6635089
    [No Abstract]   [Full Text] [Related]  

  • 70. [Topographic characteristics of the human electrodermal activity].
    Lazarev AO
    Aviakosm Ekolog Med; 2014; 48(5):64-7. PubMed ID: 26036002
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Psychometric properties of non-specific electrodermal response frequency for a sample of male students.
    Vossel G; Zimmer H
    Int J Psychophysiol; 1990 Nov; 10(1):69-73. PubMed ID: 2269650
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin.
    Shah SH; Vankar GK; Peet M; Ramchand CN
    Schizophr Res; 2000 Jun; 43(2-3):163-4. PubMed ID: 11001591
    [No Abstract]   [Full Text] [Related]  

  • 73. Maternal exposure to influenza and cold in pregnancy and electrodermal activity in offspring: the Mauritius Study.
    Venables PH
    Psychophysiology; 1997 Jul; 34(4):427-35. PubMed ID: 9260495
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Method of recording: a neglected factor in the controversy over the bimodality of electrodermal responsiveness in schizophrenic samples.
    O'Gorman JG
    Schizophr Bull; 1978; 4(2):150-2. PubMed ID: 746365
    [No Abstract]   [Full Text] [Related]  

  • 75. Investigating the potential for protective effect against non-melanoma skin cancer in cancer patients receiving oral niacin.
    Carneiro C; Nardone B; Kiguradze T; Posligua A; West DP; Rani M
    G Ital Dermatol Venereol; 2017 Aug; 152(4):387-388. PubMed ID: 28621114
    [No Abstract]   [Full Text] [Related]  

  • 76. Electrodermal indicants of arousal in brain damage: cross-validated findings.
    Parsons OA; Chandler PJ
    Psychophysiology; 1969 May; 5(6):644-59. PubMed ID: 5812327
    [No Abstract]   [Full Text] [Related]  

  • 77. [Quantitative measurement of induced skin reddening using optical reflection spectroscopy--methodology and clinical application].
    Smesny S; Riemann S; Riehemann S; Bellemann ME; Sauer H
    Biomed Tech (Berl); 2001 Oct; 46(10):280-6. PubMed ID: 11721583
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Consistency of individual differences in non-specific electrodermal activity.
    O'Gorman JG; Horneman C
    Biol Psychol; 1979 Jul; 9(1):13-21. PubMed ID: 534667
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The use of DC electrodermal potential measurements and healer's felt sense to assess the energetic nature of qi.
    Syldona M; Rein G
    J Altern Complement Med; 1999 Aug; 5(4):329-47. PubMed ID: 10471013
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Schizophrenia and lateralization of galvanic skin response.
    Claridge G
    Br J Psychiatry; 1983 Apr; 142():425-6. PubMed ID: 6850187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.